The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved January 1998

Specific Treatments:

Infections in children

General Information

Timentin (disodium/clavulanate potassium) has been approved as an injectable antibiotic for use in treating a wide range of infections in children aged 3 months to 16 years. The drug was previously approved for use in adult patients.